Federal Health Minister Dr. Jane Philpott’s announcement today at the Economic Club of Canada on “improving affordability, accessibility and appropriate use of drugs in Canada,” may well have a profound impact on drug prices in the country.
The many patient organizations participating in the Drug Pricing Policy Working Groups encourage relevant stakeholders to reconsider the way we measure the value of potential lifesaving drugs, enhance drug access in Canada and address high priced pharmaceuticals.
OTTAWA – May 16, 2017 – Read more
Save Your Skin Foundation Leads Patient Advocacy Initiative To Push For Equal, Timely Access To Innovative New Cancer Treatments
Thanks to the emergence of innovative new treatments, the last two years have marked a dramatic shift in how we look at cancer. These new treatments mean that cancer patients are not only seeing increased survival rates, but also experiencing a better quality of life while in treatment than was ever possible with standard therapies. The challenge with new treatments is ensuring that they are made accessible to patients who need them. The Save Your Skin Foundation’s advocacy initiatives are pushing for a more transparent, efficient, and agile approach to drug approval and provincial funding decisions.
Patient advocacy experts gather to start a conversation on cancer immunotherapy in Canada
Inaugural patient summit brings together experts across oncology to collaborate on patient access to innovative cancer treatments and foster collaboration among patient groups and the medical community to improve patient outcomes
TORONTO – March 27, 2017
JOINT ANNOUNCEMENT Major Step Forward in Accessing New Life-Extending Medication for Advanced Metastatic Lung, Melanoma and Kidney Cancer Patients
pCPA negotiations concluded. Provinces and Territories encouraged to quickly list.
TORONTO – February 13, 2017
Important New Cancer Treatments Approved By Health Canada Marred By Major Provincial Reality Disconnect For Patients
Patient access to innovative new cancer treatments seriously limited by provincial funding recommendations across Canada
TORONTO – November 22, 2016
Health Canada Approves First-ever Combination of Two Immuno-Oncology Agents for Metastatic Melanoma
Health Canada approves the OPDIVO® + YERVOY® regimen for previously untreated patients with unresectable or metastatic melanoma
ESMO (European Society for Medical Oncology) Breaks Records for Attendance and the Quality of Science Presented
Save Your Skin Foundation attends ESMO 2016 in Copenhagen, Denmark, taking part in the annual congress impacting the practice of oncology across the globe
Canadians with advanced skin cancer share their disease journey in empowering photo series: Melanoma Through My Lens
Campaign aims to raise awareness about different forms of the life-threatening skin cancer and its impact on patients and their families
TORONTO – August 17, 2016
Save Your Skin Foundation Recognizes National Cancer Survivors Day (Sunday, June 5th) with Greater Hope for Advanced Melanoma Survival
On the tenth anniversary of the Foundation, Cancer Survivors Day also marks a survivorship milestone for Save Your Skin Founder, Kathleen Barnard
Save Your Skin Foundation is Creating a Healthier and More Sun Safe Canada
May is Melanoma Awareness Month and the Canadian Foundation will roll out initiatives across the country to build greater awareness of skin cancer
Save Your Skin Foundation Wants You To Know It’s #NotJustSkinCancer
Tweets Inspired by Real Online Conversations Shed Light on Need for Greater Skin Cancer Awareness and Education
Together, #WeCanICan create awareness of #WorldCancerDay on February 4th!
Save Your Skin Foundation Participates in World Cancer Day #WeCanICan campaign, an Initiative of the Union for International Cancer Control (UICC)
For more press releases prior to 2016, click here
together we can make a difference
Making awareness and education available is crucial. Since 2006, the Foundation has worked to raise awareness of melanoma and non-melanoma skin cancers focusing on education, prevention and the need for improved patient care.[/action]
